P2U‐receptor mediated endothelium‐dependent but nitric oxide‐independent vascular relaxation

[1]  D. W. Cheung,et al.  Modulation of endothelium-dependent hyperpolarization and relaxation to acetylcholine in rat mesenteric artery by cytochrome P450 enzyme activity. , 1996, Circulation research.

[2]  P. Zygmunt,et al.  Effects of cytochrome P450 inhibitors on potassium currents and mechanical activity in rat portal vein , 1996, British journal of pharmacology.

[3]  P. Zygmunt,et al.  Role of potassium channels in endothelium‐dependent relaxation resistant to nitroarginine in the rat hepatic artery , 1996, British journal of pharmacology.

[4]  P. Pratt,et al.  Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. , 1996, Circulation research.

[5]  M. Parmentier,et al.  Cloning and Functional Expression of a Human Uridine Nucleotide Receptor (*) , 1995, The Journal of Biological Chemistry.

[6]  Y. Takuwa,et al.  Molecular Cloning and Functional Analysis of a Novel P2 Nucleotide Receptor (*) , 1995, The Journal of Biological Chemistry.

[7]  J. Roberts,et al.  Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. , 1995, Circulation research.

[8]  E. Raspé,et al.  Coexpression of P2Y and P2U receptors on aortic endothelial cells. Comparison of cell localization and signaling pathways. , 1995, Circulation research.

[9]  C. Garland,et al.  Endothelium-dependent hyperpolarization: a role in the control of vascular tone. , 1995, Trends in pharmacological sciences.

[10]  R. Busse,et al.  Display of the characteristics of endothelium‐derived hyperpolarizing factor by a cytochrome P450‐derived arachidonic acid metabolite in the coronary microcirculation , 1994, British journal of pharmacology.

[11]  P. Smits,et al.  Characterization of ATP-induced vasodilation in the human forearm vascular bed. , 1994, Circulation.

[12]  P. Zygmunt,et al.  Endothelium-dependent relaxation resistant to N omega-nitro-L-arginine in the rat hepatic artery and aorta. , 1994, Acta physiologica Scandinavica.

[13]  S. Archer,et al.  Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G Burnstock,et al.  Nomenclature and Classification of Purinoceptors* , 2005 .

[15]  R. Cohen,et al.  Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle , 1994, Nature.

[16]  G. Wilkinson,et al.  Differential regulation of inositol 1,4,5‐trisphosphate by co‐existing P2Y‐purinoceptors and nucleotide receptors on bovine aortic endothelial cells , 1994, British journal of pharmacology.

[17]  T. Griffith,et al.  Heterogeneous populations of K+ channels mediate EDRF release to flow but not agonists in rabbit aorta. , 1994, The American journal of physiology.

[18]  G. Burnstock,et al.  Cloning and functional expression of a brain G‐protein‐coupled ATP receptor , 1993, FEBS letters.

[19]  H. Maeda,et al.  Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.NO through a radical reaction. , 1993, Biochemistry.

[20]  M. Fujishima,et al.  Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. , 1992, Circulation research.

[21]  D. Eckman,et al.  Purinergic relaxation and hyperpolarization in guinea pig and rabbit coronary artery: role of the endothelium. , 1992, The Journal of pharmacology and experimental therapeutics.

[22]  C. Garland,et al.  Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery , 1992, British journal of pharmacology.

[23]  Y. Yamamoto,et al.  Hyperpolarization of arterial smooth muscle induced by endothelial humoral substances. , 1991, The American journal of physiology.

[24]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[25]  H. Suzuki,et al.  Endothelium-dependent hyperpolarization elicited by adenine compounds in rabbit carotid artery. , 1991, The American journal of physiology.

[26]  P. Vanhoutte,et al.  Endothelium‐derived relaxing and contracting factors , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  P. Leff,et al.  Further subclassification of ATP receptors based on agonist studies. , 1991, Trends in pharmacological sciences.

[28]  G. Burnstock.  Dual Control of Local Blood Flow by Purines a , 1990, Annals of the New York Academy of Sciences.

[29]  G. Dusting,et al.  Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium , 1990, Nature.

[30]  A. Weston,et al.  Acetylcholine releases endothelium‐derived hyperpolarizing factor and EDRF from rat blood vessels , 1988, British journal of pharmacology.

[31]  S. G. Taylor,et al.  Endothelium-derived hyperpolarizing a new endogenous inhibitor from the vascular endothelium , 1988 .

[32]  A. Weston,et al.  Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. , 1988, Trends in pharmacological sciences.

[33]  K. Komori,et al.  Heterogeneous distribution of muscarinic receptors in the rabbit saphenous artery , 1987, British journal of pharmacology.

[34]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[35]  L. Edvinsson,et al.  Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. , 1983, Acta physiologica Scandinavica.

[36]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.